Figure 8
- ID
- ZDB-FIG-261014-639
- Publication
- Ahmed et al., 2026 - TNFα-dependent modulation of WT1-MMP9 regulatory axis links developmental and inflammatory pathways in glaucoma
- Other Figures
- All Figure Page
- Back to All Figure Page
|
NOS inhibitor L-NAME inhibits WT1 translocation and restricts upregulation of MMP9 (A) Immunofluorescence of WT1 shows its localization in no treatment (i), TNF-α treated 10 and 30 min (ii and iv) and TNF-α and L-NAME co-treated cells (iii and v); scale bar, 20 μm. (B) Scatterplot shows nuclear intensity of WT1 across different treatment conditions of TNF and LNAME. Data points represent average nuclear intensity from five fields of three independent experiments; N = 3. (C) WT1 puncta numbers in the cytoplasm across these conditions are plotted. Each data point represents average of a field from three biological replicates; n = 8. (D) Immunoblot for MMP9 across time points of TNF-α treatment and L-NAME treated cell lysates. (E) Densitometric analysis of active MMP9 levels. Individual data points represent relative expression in fold change from one biological replicate; N = 3. Error bars are presented as mean ± SEM . Statistical significance was assessed by unpaired t test. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001 and ∗∗∗∗p < 0.0001. |